Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Regulatory News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

Share Price is delayed by 15 minutes
Get Live Data
1,471.00    11.00 (0.75%)
Bid:
1,475.00
Ask:
1,477.00
Spread: 2.00 (0.136%)
Market Cap: £3.13b
HIK Live PriceLast checked at - London Stock Exchange

Intraday Hikma Pharmaceuticals Share Chart

Director Declaration

29 Jul 2024 16:08

RNS Number : 2662Y
Hikma Pharmaceuticals Plc
29 July 2024
 

Hikma Pharmaceuticals PLC

Director Declaration

LONDON, 29 July 2024: Pursuant to Listing Rule 9.6.14, Hikma Pharmaceuticals PLC confirms that Victoria Hull, Senior Independent Non-Executive Director, has been appointed as a Non-Executive Director of IMI plc with effect from 1 August 2024.

- ENDS -

 

Enquiries:

 

Hikma Pharmaceuticals PLC

 

Helen Middlemist

Group Company Secretary

+44 20 7399 2760

 

Hikma Pharmaceuticals PLC (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY)

(LEI: 549300BNS685UXH4JI75)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RDNRLMATMTMTBRI
Date   Source Headline
15th May 20147:00 amRNSInterim Management Statement
6th May 20141:03 pmRNSDirector/PDMR Shareholding
17th Apr 20144:41 pmRNSAnnual Information Update
14th Apr 20145:28 pmRNSDirector/PDMR Shareholding
7th Apr 20145:28 pmRNSBlocklisting Interim Review
7th Apr 20144:27 pmRNSTotal Voting Rights
2nd Apr 20147:00 amRNSSuccessful resolution to US FDA warning letter
24th Mar 201410:23 amRNSDirector/PDMR Shareholding
12th Mar 20147:10 amRNSDirectorate Change
12th Mar 20147:00 amRNSFinal Results
27th Feb 20142:35 pmRNSNotification of major interests in shares
21st Feb 201410:24 amRNSBlock Listing of Shares
14th Feb 20147:00 amRNSTrading Statement
30th Dec 20139:50 amRNSDirector/PDMR Shareholding
20th Dec 20134:23 pmRNSDirector/PDMR Shareholding
20th Dec 20131:58 pmRNSDirector/PDMR Shareholding
16th Dec 20137:00 amRNSTotal Voting Rights
13th Dec 20137:00 amRNSHolding(s) in Company
20th Nov 20137:00 amRNSRe Agreement
11th Nov 20134:55 pmRNSDirector/PDMR Shareholding
8th Nov 20133:04 pmRNSDirector/PDMR Shareholding
8th Nov 20137:00 amRNSInterim Management Statement
25th Oct 20134:13 pmRNSDirector/PDMR Shareholding
23rd Oct 201311:40 amRNSHolding(s) in Company
18th Oct 20134:55 pmRNSDirector/PDMR Shareholding
4th Oct 20132:01 pmRNSDividend Declaration
1st Oct 201311:27 amRNSBlocklisting Interim Review
1st Oct 201311:22 amRNSTotal Voting Rights
18th Sep 20137:00 amRNSHikma entering Ethiopian pharmaceutical market
2nd Sep 20133:06 pmRNSTransaction in Own Shares
29th Aug 201311:10 amRNSTransaction in Own Shares
21st Aug 20137:00 amRNSInterim Results
31st Jul 20133:41 pmRNSDirector/PDMR Shareholding
19th Jul 20139:40 amRNSTotal Voting Rights
8th Jul 20137:00 amRNSTrading Statement
5th Jul 20134:21 pmRNSHolding(s) in Company
1st Jul 20137:00 amRNSSigning of Exclusive Agreement with Theravance
20th Jun 20133:16 pmRNSDirector/PDMR Shareholding
3rd Jun 201311:24 amRNSTotal Voting Rights
28th May 20135:24 pmRNSHolding(s) in Company
23rd May 20134:59 pmRNSDirector/PDMR Shareholding
21st May 20133:36 pmRNSDirector/PDMR Shareholding
20th May 20139:42 amRNSDirector/PDMR Shareholding
16th May 20133:32 pmRNSResult of AGM
16th May 20137:00 amRNSInterim Management Statement
10th May 20133:05 pmRNSDirector/PDMR Shareholding
2nd May 20133:16 pmRNSDirector/PDMR Shareholding
23rd Apr 20133:32 pmRNSDirector/PDMR Shareholding
18th Apr 201310:29 amRNSDirector/PDMR Shareholding
17th Apr 20137:00 amRNSHikma update on global Injectables business

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.